Access cutting-edge brain cancer treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.
Access brain cancer specialists in Richmond at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain cancer treatment provided free
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Sponsor: InSightec
Check if you qualify for this brain cancer clinical trial in Richmond, VA
If you're searching for brain cancer treatment options in Richmond, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.